Preparing your Praveta Brief...
Based on official legislative actions published by Congress.
Referred to the House Committee on Energy and Commerce.
This timeline shows the bill's position in the federal legislative process based on official congressional actions.
Referred to the House Committee on Energy and Commerce.
Praveta hasn't published a community poll for this bill yet. If one becomes available, you'll be able to participate and see results here.
Praveta uses official congressional material as its source of truth. You can review the underlying record directly.
The bill would create a federal program to coordinate education, grants, research, and reporting on blood cancer.
Creates the National Blood Cancer Program at HHS
Authorizes grants to health agencies and nongovernmental entities
Authorizes grants to colleges and academic medical centers for diagnostics
Requires annual reports to Congress starting within one year
If enacted, the bill would create a coordinated federal effort to fund education, research, and access initiatives for blood cancer, and would require annual congressional reporting on program activities and reach.
Federal health agencies, state/local/Tribal health entities, institutes of higher education, and academic medical centers would be affected.
Introduced in the House on October 22, 2026, and referred to the House Energy and Commerce Committee; no vote recorded in the source.
Praveta summarizes official congressional material and keeps the underlying source available for review.